Mesa Laboratories, Inc.
NASDAQ:MLABHardware, Equipment & Parts
-$0.15 today
- Market cap
- $774.56M
- Beta
- 0.93
- P/E (TTM)
- 78.3
- EPS (TTM)
- $1.21
- Dividend yield
- 0.68%
Volume 0.07M
Average 0.16M
Returns on capital
Mesa Laboratories, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
3.6%
avg -12.9%
ROIC
2.8%
avg -4.5%
ROA
1.6%
avg -3.5%
Analysis
ROE is currently the strongest return metric at 3.6% versus its period average of -12.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Siddhartha Chandrakant Kadia | Chief Executive Officer, President & Director | USD 2M | 56 | — | — |
John V. Sakys | VP & CFO | USD 921.39K | 57 | — | — |
Brian David Archbold | Senior Vice President of Operations & Continuous Improvement | USD 782.44K | 51 | 6.38K | 0.12% |
Lyndsey Crennen | Chief Accounting Officer | — | 41 | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jun 22, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
5
$1.35M
Sells
7
$1.57M
Net Transaction Value
−$215,729.08
Net selling
Most Active
Tripeny R Tony
2 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Aug 13, 26Aug 13, 2026 | Kadia Siddhartha Indirect | Buy | $800.1K$800,090.40 |
| Aug 13, 26Aug 13, 2026 | Sullivan John James Direct | Sell | $800.1K$800,090.40 |
| Aug 13, 26Aug 13, 2026 | Tripeny R Tony Direct | Buy | $102.3K$102,321.00 |
| Jun 22, 26Jun 22, 2026 | Crennen Lyndsey Elizabeth Direct | Sell | $39.6K$39,559.88 |
| Jun 22, 26Jun 22, 2026 | Archbold Brian David Direct | Sell | $225.2K$225,187.03 |
| Jun 22, 26Jun 22, 2026 | Sakys John Direct | Sell | $253K$253,022.15 |
| Jun 16, 26Jun 16, 2026 | Archbold Brian David Direct | Sell | $116.6K$116,558.32 |
| Jun 16, 26Jun 16, 2026 | Crennen Lyndsey Elizabeth Direct | Sell | $11.9K$11,949.51 |
| Jun 16, 26Jun 16, 2026 | Sakys John Direct | Sell | $123.8K$123,849.54 |
| Mar 10, 26Mar 10, 2026 | Ladiwala Shiraz Shabanali Direct | Buy | $252.8K$252,805.00 |
1–10 of 12
Summary
Insiders reported 5 buys worth $1.35M and 7 sells worth $1.57M over the last 12 months. That adds up to net selling of $215,729.08. Tripeny R Tony was the most active insider with 2 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +92.4% | N/A0 analysts |
| Revenue | N/A | N/A | +4.4% | +3.6% (3yr)1 analysts |
| Net Income | N/A | N/A | +93.3% | N/A1 analysts |
| EBIT | N/A | N/A | +77.3% | N/A — |
Analysis
Recent growth has been strongest in Net Income at +93.3% over three years. Forward estimates point to Revenue at +3.6% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Mesa Laboratories, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about MLAB's management, answered from reported figures.
Who manages MLAB?
Mesa Laboratories, Inc. (MLAB) lists 4 active executives. The top listed executive is Siddhartha Chandrakant Kadia, Chief Executive Officer, President & Director.
Are MLAB insiders buying or selling?
Recent insider activity shows net selling of $8.40M.
Continue the stock analysis
Jump to another research area for this company.